Mente; Scot Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mente; Scot Richard.The latest application filed is for "heteroaromatic macrocyclic ether chemotherapeutic agents".

Company Profile

16.22.36

Mente; Scot Richard - Arlington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaromatic Macrocyclic Ether Chemotherapeutic Agents App 20220098212 - Horan; Joshua Courtney ; et al.	2022-03-31
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20210300899 - Brodney; Michael Aaron ; et al.	2021-09-30
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 11,014,909 - Brodney , et al. May 25, 2	2021-05-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20200283407 - Brodney; Michael Aaron ; et al.	2020-09-10
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,696,658 - Brodney , et al. June 30, 2	2020-06-30
Rorc2 Inhibitors And Methods Of Use Thereof App 20200039960 - Schnute; Mark Edward ; et al.	2020-02-06
Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20190387710 - Schnute; Mark Edward ; et al.	2019-12-26
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190367485 - Brodney; Michael Aaron ; et al.	2019-12-05
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Grant 10,426,135 - Schnute , et al. October 1, 2	2019-10-01
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,421,744 - Brodney , et al. Sept	2019-09-24
Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof Grant 10,385,036 - Schnute , et al. A	2019-08-20
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Grant 10,336,748 - Schnute , et al.	2019-07-02
Heteroarylphenoxy benzamide kappa opioid ligands Grant 10,316,021 - Kablaoui , et al.	2019-06-11
Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20190150401 - Schnute; Mark Edward ; et al.	2019-05-23
Rorc2 Inhibitors And Methods Of Use Thereof App 20190144429 - Schnute; Mark Edward ; et al.	2019-05-16
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof Grant 10,227,346 - Schnute , et al.	2019-03-12
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190002439 - BRODNEY; MICHAEL AARON ; et al.	2019-01-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180346477 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-12-06
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,093,655 - Brodney , et al. October 9, 2	2018-10-09
Rorc2 Inhibitors And Methods Of Use Thereof App 20180282304 - Schnute; Mark Edward ; et al.	2018-10-04
Sulfonamide-Substituted Indole Modulators of RORC2 and Methods of Use Thereof App 20180273504 - Schnute; Mark Edward ; et al.	2018-09-27
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,077,272 - Gray , et al. September 18, 2	2018-09-18
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20180200253 - COE; JOTHAM WADSWORTH ; et al.	2018-07-19
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20180170928 - SCHNUTE; MARK EDWARD ; et al.	2018-06-21
Heteroarylphenoxy Benzamide Kappa Opioid Ligands App 20180148432 - Kablaoui; Natasha Mariam ; et al.	2018-05-31
Rorc2 Inhibitors And Methods Of Use Thereof App 20180086736 - Schnute; Mark Edward ; et al.	2018-03-29
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180072750 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-03-15
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180037571 - BRODNEY; MICHAEL AARON ; et al.	2018-02-08
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,868,744 - Gray , et al. January 16, 2	2018-01-16
Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20180002330 - Schnute; Mark Edward ; et al.	2018-01-04
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,856,263 - Gray , et al. January 2, 2	2018-01-02
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,822,097 - Brodney , et al. November 21, 2	2017-11-21
Rorc2 Inhibitors And Methods Of Use Thereof App 20170233371 - Schnute; Mark Edward ; et al.	2017-08-17
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20170233390 - SCHNUTE; MARK EDWARD ; et al.	2017-08-17
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,688,698 - Gray , et al. June 27, 2	2017-06-27
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20170165270 - COE; JOTHAM WADSWORTH ; et al.	2017-06-15
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Grant 9,670,201 - Schnute , et al. June 6, 2	2017-06-06
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,617,275 - Coe , et al. April 11, 2	2017-04-11
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170057947 - BRODNEY; MICHAEL AARON ; et al.	2017-03-02
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037053 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-09
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037049 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-09
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,831 - Brodney , et al. December 27, 2	2016-12-27
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,843 - Davoren , et al. December 27, 2	2016-12-27
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof App 20160090381 - SCHNUTE; MARK EDWARD ; et al.	2016-03-31
Rorc2 Inhibitors And Methods Of Use Thereof App 20160046597 - Schnute; Mark Edward ; et al.	2016-02-18
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150344490 - COE; JOTHAM WADSWORTH ; et al.	2015-12-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150344474 - DAVOREN; JENNIFER ELIZABETH ; et al.	2015-12-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150307522 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2015-10-29
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150291625 - COE; JOTHAM WADSWORTH ; et al.	2015-10-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,139,561 - Brodney , et al. September 22, 2	2015-09-22
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,133,190 - Davoren , et al. September 15, 2	2015-09-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,107,923 - Brodney , et al. August 18, 2	2015-08-18
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150196561 - BRODNEY; MICHAEL AARON ; et al.	2015-07-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150175573 - BRODNEY; MICHAEL AARON ; et al.	2015-06-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150005313 - BRODNEY; MICHAEL AARON ; et al.	2015-01-01
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140336176 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-11-13
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 8,822,494 - Davoren , et al. September 2, 2	2014-09-02
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140128374 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-05-08